Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?

article

Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JAC/DKS435
P698PubMed publication ID23111850

P50authorMaree SmithQ24851696
Jason A. RobertsQ38544404
Kiran ShekarQ58396529
Steven C WallisQ58397119
P2093author name stringJohn F Fraser
Daniel V Mullany
Sussan Ghassabian
P2860cites workMeropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltrationQ24620193
Pharmacokinetics in the newbornQ35111481
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenationQ36928231
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patientsQ39487652
Determinants of drug absorption in different ECMO circuits.Q42362818
Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of conceptQ42946682
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.Q46034494
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectpharmacokineticsQ323936
extracorporeal membrane oxygenationQ1385195
P1104number of pages2
P304page(s)726-727
P577publication date2012-10-30
P1433published inJournal of Antimicrobial ChemotherapyQ6294770
P1476titleAltered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?
P478volume68

Reverse relations

cites work (P2860)
Q34494688ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.
Q41554621Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation
Q33821972Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?
Q51581871Azithromycin Pharmacokinetics in Adults With Acute Respiratory Distress Syndrome Undergoing Treatment With Extracorporeal-Membrane Oxygenation.
Q90267103Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge
Q55145216Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.
Q39188586Medicating patients during extracorporeal membrane oxygenation: the evidence is building
Q30811829Optimal management of the critically ill: anaesthesia, monitoring, data capture, and point-of-care technological practices in ovine models of critical care
Q47632337Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Q88271342Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients
Q51702479Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support.
Q30249512Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review
Q54257517Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment.
Q41052029Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood
Q36928231Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation
Q40223593Successful use of extracorporeal membrane oxygenation in a human immunodeficiency virus infected patient with severe acute respiratory distress syndrome
Q34630847The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation
Q34996307The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study

Search more.